P41 10mg*10vials

PT-141 (P41) 10mg x 10 Vials

Product Overview

PT-141 (P41) is a synthetic peptide in the CN neuroendocrine and physiological regulation series. As the basic standard version of Bremelanotide, P41 forms a complete tiered product line with the high-end PNC27 premium version. This product is a highly active and selective MC4R melanocortin receptor agonist with excellent blood-brain barrier permeability, zero immunogenicity, and high biocompatibility. The standard 10mg dose enables gentle, precise, and reproducible endogenous neuroendocrine regulation. Utilizing a biomimetic mechanism, P41 targets the central melanocortin signaling pathway, pelvic microcirculation, and the hypothalamic metabolic axis, stably regulating neurobehavioral responses, autonomic nervous function, and energy metabolism balance. It is ideally suited for basic preclinical mechanism validation, low-threshold physiological modeling, and baseline peptide synergistic studies, serving as a core standard research material for neuroendocrine physiology research.

Core Research Functions

Central MC4R Pathway Activation: Stably activates central MC4R receptors, regulating limbic system reward pathways and dopamine release, maintaining normal neurobehavioral and motivational physiological responses.

Pelvic Microcirculation Optimization: Gently dilates peripheral pelvic microvessels, optimizing local blood perfusion and stabilizing autonomic nervous system physiological arousal function.

Hypothalamic Metabolic Regulation: Regulates hypothalamic energy metabolism signals, balancing appetite and energy expenditure, supporting basal metabolic homeostasis for weight regulation research.

Neuroprotective Support: Exerts a mild central nervous system protective effect, alleviating low-grade neuroinflammation and neurological stress, and stabilizing the central nervous system immune microenvironment.

Mild melanocortin pathway dysregulation, poor microcirculation, and basal metabolic imbalance are common factors in physiological sub-health and neuroendocrine function fluctuations. P41 employs physiologically biomimetic intervention with stable intensity, providing reliable baseline experimental data for exploring PT-141 mechanisms, modeling physiological homeostasis, and validating peptide combinations.

Key Advantages

Stable MC4R Baseline Activation: Highly selectively targets the melanocortin receptor, ensuring stable and moderate pathway activation without excessive intervention, ideal for basic functional validation and control group experiments.

Gentle Microcirculation Regulation: Gently optimizes pelvic blood perfusion and autonomic nerve stability, suitable for studies on basic physiological circulatory remodeling and autonomic nerve function mechanisms.

Basal Metabolic Homeostasis: Stabilizes and balances energy intake and expenditure, improving mild metabolic sub-health conditions, providing a reliable baseline model for basic metabolic physiological research.

High Safety and Neuroimmune Stability: Gently alleviates low-grade neuroinflammation, maintains neural microenvironment balance, with good biocompatibility and no immune interference, suitable for long-term baseline intervention experiments.

Standard High-Purity Process: Employs gradient purification and vacuum lyophilization technology, ensuring uniform activity and extremely low impurity content, guaranteeing high consistency and reproducibility of experimental data.

Standard Aseptic Packaging and Quality Control: Packaged in 10-vial dust-free aseptic packs, fully tested for purity by HPLC, and accompanied by a complete Certificate of Analysis (COA), suitable for routine laboratory research and bulk purchases.

Specifications and Quality Control

Format: Lyophilized powder, 10mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).